TOPICORT
As listed in the register: TOPICORT
0.25 % · ointment
- Prescription only
- Skin
- Active substance
- Desoximetasone
- Used in
- Skin
- Made by
- Bausch Health, Canada Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Desoximetasone). It describes the substance, not this exact product.
Corticosteroids play a role in cellular signaling, immune function, inflammation and protein regulation; however, the precise mechanism of action in psoriasis is unknown.
Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-11-13
Safety of the active substance
From the US prescribing label for the same active substance (Desoximetasone). It describes the substance, not this exact product.
The most common adverse reactions (≥ 1%) are application site dryness, application site irritation and application site pruritus.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Bausch Health, Canada Inc. |
|---|---|
| Active substance | Desoximetasone |
| Used in | Skin |
| Strength | 0.25 % |
| Form | ointment |
| Classification | D07AC03 · Skin |
| Route | topical |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02221934 |
| DPD drug code | 43317 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.